Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
0.0400
0.0000
0.00%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks! Unlock list
Hemostemix Inc (HEM)
Add to/Remove from a Portfolio
Add to Watchlist
- Volume: 91,000
- Bid/Ask: 0.0400 / 0.0450
- Day's Range: 0.0400 - 0.0450
Type:
Equity
Market:
Canada
Hemostemix Inc
0.0400
0.0000
0.00%
- General
- Chart
- News & Analysis
- Financials
- Technical
- Forum
HEM Cash Flow Statement
Featured here, the Cash Flow Statement for Hemostemix Inc, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
| Period Ending: | 2023 31/12 |
2023 30/09 |
2023 30/06 |
2023 31/03 |
|||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Length: | 0 Months | 0 Months | 0 Months | 0 Months | |||||||||||||||||||||||||||||||||||||||||||||
| Net Income/Starting Line | - | -0.257 | - | -1.28 | |||||||||||||||||||||||||||||||||||||||||||||
| Cash From Operating Activities | -0.24 | -0.066 | - | -0.711 | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
| Cash From Investing Activities | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
| Cash From Financing Activities | 0.018 | 0.289 | - | 0.848 | |||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign Exchange Effects | -0.087 | 0.036 | - | -0.037 | |||||||||||||||||||||||||||||||||||||||||||||
| Net Change in Cash | -0.222 | 0.223 | - | 0.137 | |||||||||||||||||||||||||||||||||||||||||||||
| Beginning Cash Balance | 0.378 | 0.154 | - | 0.136 | |||||||||||||||||||||||||||||||||||||||||||||
| Ending Cash Balance | 0.155 | 0.378 | - | 0.272 | |||||||||||||||||||||||||||||||||||||||||||||
| Free Cash Flow | 0.084 | -0.224 | -0.692 | -0.292 | |||||||||||||||||||||||||||||||||||||||||||||
| Free Cash Flow Growth | 137.36 | 67.64 | -136.97 | 36.46 | |||||||||||||||||||||||||||||||||||||||||||||
| Free Cash Flow Yield | - | -0.652 | - | -5.52 | |||||||||||||||||||||||||||||||||||||||||||||
* In Millions of CAD (except for per share items)
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Write your thoughts about Hemostemix Inc
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Lucas zex
Oct 31, 2023 10:47
The negative impact on the stock market stemming from $HEM's poor services has been a source of disappointment for investors who have suffered losses. I also suffered losses.
0
0
William max
Oct 31, 2023 7:39
Shareholders of $HEM face a challenging situation as the company's profitability remains elusive, casting shadows of uncertainty over the company's future.
0
0
Markis jax
Oct 30, 2023 14:37
$HEM's stock continued to underperform, with a 15% decrease to $0.085 on the previous trading day, resulting in financial losses for investors.
0
0
James Macho
Oct 30, 2023 8:43
$HEM continues to struggle financially, with no signs of profitability in sight. Shareholders are left with uncertainty about the company's future.
0
0
ranchhodd das
May 08, 2023 14:04
The technical analysis of the stock $HEM shows that it is trading at an affordable price, with more than 81 million outstanding shares. As a healthcare stock, it will be a good option for long-term investors .
0
0
Jack Mallick
May 05, 2023 9:44
This stock has proven to be a trustworthy pick for investors seeking consistent, long-term gains. Its steadiness has made it an attractive option among investors, as seen by the high number of 65K shares traded yesterday.
0
0
Braxton lee
May 04, 2023 10:33
$HEM has consistently delivered a good return. The company has maintained financial stability and has the potential to continue bolstering its market share in the coming months.
0
0
Jack Mallick
May 01, 2023 10:41
The company has a market capitalization of $12.97 million and has been gaining popularity among investors due to its low-cost offering and potential for future growth. HEM has a diversified portfolio of investments and a well-managed balance sheet, which gives investors confidence in the company's long-term stability and future prospects.
0
0
ranchhodd das
Apr 25, 2023 15:43
Hemostemix is looking to expand and has been conducting interviews for a new Executive VP of Business Development. The stock is trading at a pocket friendly price over TSX-V .
0
0
ranchhodd das
Apr 17, 2023 10:42
The technical analysis of the stock $HEM shows that it is trading at an affordable price, with more than 81 million outstanding shares. As a healthcare stock, it looks quite profitable for long-term investors.
0
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review